Healthcare - Biotechnology - NASDAQ - US
$ 0.0003
0 %
$ 12.6 K
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-8.13 M
OPERATING CASH FLOW
-1.55 K
INVESTING CASH FLOW
242 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Scopus BioPharma Inc.
| Net Income | -11.7 M |
| Depreciation & Amortization | 1.73 K |
| Capital Expenditures | -1.55 K |
| Stock-Based Compensation | 352 K |
| Change in Working Capital | 3.23 M |
| Others | -3 B |
| Free Cash Flow | -8.13 M |
Cash Flow
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (11.7) | (27.0) | (10.9) | (2.7) | (0.7) |
| Depreciation & Amortization | 1.73 K | 1.5 K | 1.44 K | 664 | 0 |
| Deferred Income Tax | 0 | (1.5) | 0 | 0 | 0 |
| Stock Based Compensation | 0.4 | 0.7 | 0.3 | 0.2 | 69.6 K |
| Other Operating Activities | 0 | 13.5 | 6.9 | 89.2 K | 0 |
| Change in Working Capital | 3.2 | 2.8 | 1.1 | 0.4 | (0.1) |
| Cash From Operations | (8.1) | (11.4) | (2.5) | (2.1) | (0.7) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 1.55 K | 2 K | 0 | 4.25 K | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 1.55 K | 2 K | 0 | 4.25 K | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (0.1) | 2.2 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.2 | (2.4) | (1.1) | 0.4 | 59.1 K |
| Cash From Financing Activities | 0.2 | 17.6 | 4.4 | 2.2 | 0.6 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (7.8) | 6.1 | 1.8 | 35.1 K | (0.2) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (8.1) | (11.4) | (2.5) | (2.1) | (0.7) |